BRKR
Bruker Corporation
Medical - Devices
Market Cap$6.44B
5Y Perf.-2.3%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
BRKR vs A
Revenue, margins, valuation, and 5-year total return — side by side.
A
Agilent Technologies, Inc.
Medical - Diagnostics & Research
Market Cap$33.31B
5Y Perf.+33.5%
BRKR vs A — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | BRKR | A |
|---|---|---|
| Industry | Medical - Devices | Medical - Diagnostics & Research |
| Market Cap | $6.44B | $33.31B |
| Revenue (TTM) | $3.46B | $7.07B |
| Net Income (TTM) | $-26M | $1.29B |
| Gross Margin | 45.3% | 38.8% |
| Operating Margin | 4.9% | 20.6% |
| Forward P/E | 20.0x | 19.7x |
| Total Debt | $2.04B | $3.35B |
| Cash & Equiv. | $299M | $1.79B |
BRKR vs A — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
BRKR
A
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Bruker Corporation (BRKR) | 100 | 97.7 | -2.3% |
| Agilent Technologie… (A) | 100 | 133.5 | +33.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BRKR vs A
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: A leads in 7 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
BRKR
Bruker Corporation
The Specific-Use Pick
In this particular matchup, BRKR is outpaced on most metrics by others in the set.
Best for: healthcare exposure
A
Agilent Technologies, Inc.
The Income Pick
A carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 10 yrs, beta 1.23, yield 0.8%
- Rev growth 6.7%, EPS growth 3.2%, 3Y rev CAGR 0.5%
- 202.6% 10Y total return vs BRKR's 59.6%
Best for: income & stability and growth exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | A | 6.7% revenue growth vs BRKR's 2.1% |
| Value | A | Lower P/E (19.7x vs 20.0x) |
| Quality / Margins | A | 18.3% margin vs BRKR's -0.8% |
| Stability / Safety | A | Beta 1.23 vs BRKR's 1.59, lower leverage |
| Dividends | A | 0.8% yield, 10-year raise streak, vs BRKR's 0.4% |
| Momentum (1Y) | A | +12.8% vs BRKR's +7.7% |
| Efficiency (ROA) | A | 10.1% ROA vs BRKR's -0.4%, ROIC 13.5% vs 4.4% |
BRKR vs A — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
BRKR vs A — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLALAGGINGBRKR
BRKRBruker Corporation
1leads
AAgilent Technologies,…
4leads
6 Total Categories
CATEGORYLEADERvs BRKRMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
A5/6
Valuation MetricsMultiples, price ratios, and targets
BRKR4/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
A8/9
Total Returns1Y, 3Y, 5Y total returns with dividends
A5/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
A2/2
Income & Cash Flow (Last 12 Months)
A leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
A is the larger business by revenue, generating $7.1B annually — 2.0x BRKR's $3.5B. A is the more profitable business, keeping 18.3% of every revenue dollar as net income compared to BRKR's -0.8%. On growth, A holds the edge at +7.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | BRKRBruker Corporation | AAgilent Technolog… |
|---|---|---|
| RevenueTrailing 12 months | $3.5B | $7.1B |
| EBITDAEarnings before interest/tax | $339M | $1.7B |
| Net IncomeAfter-tax profit | -$26M | $1.3B |
| Free Cash FlowCash after capex | $51M | $993M |
| Gross MarginGross profit ÷ Revenue | +45.3% | +38.8% |
| Operating MarginEBIT ÷ Revenue | +4.9% | +20.6% |
| Net MarginNet income ÷ Revenue | -0.8% | +18.3% |
| FCF MarginFCF ÷ Revenue | +1.5% | +14.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.7% | +7.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -81.8% | -3.6% |
A leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
BRKR leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, BRKR's 17.9x EV/EBITDA is more attractive than A's 19.7x.
| Metric | BRKRBruker Corporation | AAgilent Technolog… |
|---|---|---|
| Market CapShares × price | $6.4B | $33.3B |
| Enterprise ValueMkt cap + debt − cash | $8.2B | $34.9B |
| Trailing P/EPrice ÷ TTM EPS | -282.00x | 25.75x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.01x | 19.71x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.75x |
| EV / EBITDAEnterprise value multiple | 17.93x | 19.74x |
| Price / SalesMarket cap ÷ Revenue | 1.87x | 4.79x |
| Price / BookPrice ÷ Book value/share | 2.56x | 4.96x |
| Price / FCFMarket cap ÷ FCF | 148.71x | 28.92x |
BRKR leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
A leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
A delivers a 18.7% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-1 for BRKR. A carries lower financial leverage with a 0.50x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRKR's 0.81x. On the Piotroski fundamental quality scale (0–9), A scores 5/9 vs BRKR's 4/9, reflecting solid financial health.
| Metric | BRKRBruker Corporation | AAgilent Technolog… |
|---|---|---|
| ROE (TTM)Return on equity | -1.1% | +18.7% |
| ROA (TTM)Return on assets | -0.4% | +10.1% |
| ROICReturn on invested capital | +4.4% | +13.5% |
| ROCEReturn on capital employed | +5.0% | +14.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.81x | 0.50x |
| Net DebtTotal debt minus cash | $1.7B | $1.6B |
| Cash & Equiv.Liquid assets | $299M | $1.8B |
| Total DebtShort + long-term debt | $2.0B | $3.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.75x | 19.53x |
A leads this category, winning 8 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
A leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in A five years ago would be worth $9,234 today (with dividends reinvested), compared to $6,345 for BRKR. Over the past 12 months, A leads with a +12.8% total return vs BRKR's +7.7%. The 3-year compound annual growth rate (CAGR) favors A at -3.1% vs BRKR's -17.8% — a key indicator of consistent wealth creation.
| Metric | BRKRBruker Corporation | AAgilent Technolog… |
|---|---|---|
| YTD ReturnYear-to-date | -12.0% | -14.3% |
| 1-Year ReturnPast 12 months | +7.7% | +12.8% |
| 3-Year ReturnCumulative with dividends | -44.4% | -9.0% |
| 5-Year ReturnCumulative with dividends | -36.6% | -7.7% |
| 10-Year ReturnCumulative with dividends | +59.6% | +202.6% |
| CAGR (3Y)Annualised 3-year return | -17.8% | -3.1% |
A leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
Evenly matched — BRKR and A each lead in 1 of 2 comparable metrics.
Risk & Volatility
A is the less volatile stock with a 1.23 beta — it tends to amplify market swings less than BRKR's 1.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | BRKRBruker Corporation | AAgilent Technolog… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.59x | 1.23x |
| 52-Week HighHighest price in past year | $56.22 | $160.27 |
| 52-Week LowLowest price in past year | $28.53 | $104.36 |
| % of 52W HighCurrent price vs 52-week peak | +75.2% | +73.4% |
| RSI (14)Momentum oscillator 0–100 | 52.6 | 52.2 |
| Avg Volume (50D)Average daily shares traded | 1.9M | 2.0M |
Evenly matched — BRKR and A each lead in 1 of 2 comparable metrics.
Analyst Outlook
A leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates BRKR as "Buy" and A as "Buy". Consensus price targets imply 41.0% upside for A (target: $166) vs 23.2% for BRKR (target: $52). For income investors, A offers the higher dividend yield at 0.84% vs BRKR's 0.36%.
| Metric | BRKRBruker Corporation | AAgilent Technolog… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $52.13 | $166.00 |
| # AnalystsCovering analysts | 32 | 38 |
| Dividend YieldAnnual dividend ÷ price | +0.4% | +0.8% |
| Dividend StreakConsecutive years of raises | 0 | 10 |
| Dividend / ShareAnnual DPS | $0.15 | $0.99 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | +1.3% |
A leads this category, winning 2 of 2 comparable metrics.
Key Takeaway
A leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BRKR leads in 1 (Valuation Metrics). 1 tied.
Best OverallAgilent Technologies, Inc. (A)Leads 4 of 6 categories
Loading custom metrics...
BRKR vs A: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is BRKR or A a better buy right now?
For growth investors, Agilent Technologies, Inc.
(A) is the stronger pick with 6. 7% revenue growth year-over-year, versus 2. 1% for Bruker Corporation (BRKR). Agilent Technologies, Inc. (A) offers the better valuation at 25. 8x trailing P/E (19. 7x forward), making it the more compelling value choice. Analysts rate Bruker Corporation (BRKR) a "Buy" — based on 32 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BRKR or A?
On forward P/E, Agilent Technologies, Inc.
is actually cheaper at 19. 7x.
03Which is the better long-term investment — BRKR or A?
Over the past 5 years, Agilent Technologies, Inc.
(A) delivered a total return of -7. 7%, compared to -36. 6% for Bruker Corporation (BRKR). Over 10 years, the gap is even starker: A returned +202. 6% versus BRKR's +59. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BRKR or A?
By beta (market sensitivity over 5 years), Agilent Technologies, Inc.
(A) is the lower-risk stock at 1. 23β versus Bruker Corporation's 1. 59β — meaning BRKR is approximately 29% more volatile than A relative to the S&P 500. On balance sheet safety, Agilent Technologies, Inc. (A) carries a lower debt/equity ratio of 50% versus 81% for Bruker Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — BRKR or A?
By revenue growth (latest reported year), Agilent Technologies, Inc.
(A) is pulling ahead at 6. 7% versus 2. 1% for Bruker Corporation (BRKR). On earnings-per-share growth, the picture is similar: Agilent Technologies, Inc. grew EPS 3. 2% year-over-year, compared to -119. 7% for Bruker Corporation. Over a 3-year CAGR, BRKR leads at 10. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BRKR or A?
Agilent Technologies, Inc.
(A) is the more profitable company, earning 18. 8% net margin versus -0. 3% for Bruker Corporation — meaning it keeps 18. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: A leads at 21. 3% versus 6. 9% for BRKR. At the gross margin level — before operating expenses — A leads at 52. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BRKR or A more undervalued right now?
On forward earnings alone, Agilent Technologies, Inc.
(A) trades at 19. 7x forward P/E versus 20. 0x for Bruker Corporation — 0. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for A: 41. 0% to $166. 00.
08Which pays a better dividend — BRKR or A?
All stocks in this comparison pay dividends.
Agilent Technologies, Inc. (A) offers the highest yield at 0. 8%, versus 0. 4% for Bruker Corporation (BRKR).
09Is BRKR or A better for a retirement portfolio?
For long-horizon retirement investors, Agilent Technologies, Inc.
(A) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 23), 0. 8% yield, +202. 6% 10Y return). Bruker Corporation (BRKR) carries a higher beta of 1. 59 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (A: +202. 6%, BRKR: +59. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BRKR and A?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
A pays a dividend while BRKR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(BRKR: 2.7% · A: 7.0%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.